Multicenter, open-label follow-up study on the safety of enteric-coated mycophenolate sodium in de novo renal transplant patients

Trial Profile

Multicenter, open-label follow-up study on the safety of enteric-coated mycophenolate sodium in de novo renal transplant patients

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Oct 2009

At a glance

  • Drugs Mycophenolate sodium (Primary)
  • Indications Renal transplant rejection
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 06 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top